Orphazyme

Scroll
Investment area
Novo Ventures
Region
Europe
Date of investment
August 2011
Website
http://www.orphazyme.com/

Orphazyme develops novel therapeutics for the treatment of lysosomal storage diseases. The company is preparing the lead programme for a phase 2/3 registration-enabling clinical trial in Niemann-Pick disease type C.